VIVITROL (naltrexone for extended-release injectable suspension) a) 380 mg vial NDC 65757-303-02, b) 380 mg vial in kit NDC 65757-300-01, Rx Only Manufactured and marketed by Alkermes, Inc., Waltham, MA 02451,
Published July 31, 2013 · Recall initiated: November 6, 2012
Summary
FDA records drug Class II recall D-819-2013, published July 31, 2013 and initiated November 6, 2012. Recalling firm: Alkermes, Inc.; Status: Terminated; Reported quantity: 3,325 vials; Lot: Individual vial lot 402-3683AA, EXP 10/13; kit vial lot 2011-003, EXP 08/13. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility: Product did not meet the criteria for container closure integrity testing during routine 24 month stability testing.
What to do
Voluntary: Firm initiated · Letter
Get an email if VIVITROL has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- VIVITROL
- Manufacturer
- Alkermes, Inc.
- Distributor
- Nationwide
- Lot
- Individual vial lot 402-3683AA, EXP 10/13; kit vial lot 2011-003, EXP 08/13
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAVivitrol (naltrexone for extended-release injectable suspension) 380 mg/vial. Each Carton Contains: 1) OneOctober 9, 2019
- FDAVIVITROL (naltrexone for extended-release injectable suspension); 380 mg vial NDC 65757-300-01; RX OnlySeptember 3, 2014
- FDAOxygen, Compressed USP UN1072 Medical Gas supplied in a) 682 litres and b)165 litres cylinders, Rx only,July 31, 2013
- FDAAmBisome (amphotericin B) liposome for injection, 50mg vial, single use vial, For Intravenous Infusion Only,July 31, 2013
- FDADiclofenac Sodium and Misoprostol Delayed-Release Tablets, 75mg/0.2mg, 60-count bottle, Rx only, ManufacturedJuly 31, 2013
- FDAAmBisome (amphotericin B) liposome for Injection, 50 mg, For Intravenous Infusion Only, Single-Use Vial, RxJuly 31, 2013
Questions about this recall
Was VIVITROL (naltrexone for extended-release injectable suspension) a) 380 mg vial NDC 65757-303-02, b) 380 mg vial in kit NDC 65757-300-01, Rx Only Manufactured and marketed by Alkermes, Inc., Waltham, MA 02451, recalled?
Yes. FDA published recall D-819-2013 on July 31, 2013. Reported hazard: Lack of Assurance of Sterility: Product did not meet the criteria for container closure integrity testing during routine 24 month stability testing.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: VIVITROL.